Search by Drug Name or NDC

    NDC 52817-0380-10 Naproxen 375 mg/1 Details

    Naproxen 375 mg/1

    Naproxen is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by TruPharma LLC. The primary component is NAPROXEN.

    Product Information

    NDC 52817-0380
    Product ID 52817-380_0177ebbe-5e72-1fb4-e063-6294a90ab32b
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Naproxen
    Proprietary Name Suffix n/a
    Non-Proprietary Name Naproxen
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 375
    Active Ingredient Units mg/1
    Substance Name NAPROXEN
    Labeler Name TruPharma LLC
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA216908
    Listing Certified Through 2024-12-31

    Package

    NDC 52817-0380-10 (52817038010)

    NDC Package Code 52817-380-10
    Billing NDC 52817038010
    Package 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (52817-380-10)
    Marketing Start Date 2023-08-01
    NDC Exclude Flag N
    Pricing Information N/A